dr. reddy's labs glp-1 receptor agonist weight management diabetes treatments Laboratories has entered the fast-growing therapy segment with the launch of its semaglutide generic, Obeda, for Type 2 in India's โน1,446 crore market. ๐๐๐๐ ๐๐ฎ๐ฅ๐ฅ ๐๐ซ๐ญ๐ข๐๐ฅ๐ ๐จ๐ง ๐จ๐ฎ๐ซ India's Dr Reddy's plans to
Pay in 4 interest-free payments of $5.19 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 6 - Aug 11



























